← European Medicine Shortage Tracker · all medicines

Bempedosäure, ezetimib shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Bempedosäure, ezetimib currently has availability issues reported in 1 European register: Austria.

Shortage  ATC C10B · also listed as: BEMPEDOSÄURE, EZETIMIB · data refreshed 28 October 2026

Key facts

As of 28 October 2026, 1 of the 10 tracked registers list current availability issues for Bempedosäure, ezetimib, covering 1 affected product presentation. Where agencies state a cause, manufacturing problems lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2027-01-25; the earliest is 2027-01-25. In the WHO ATC classification, Bempedosäure, ezetimib is coded C10B — a medicine acting on the cardiovascular system — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇦🇹 AustriaShortage
Nustendi 180 mg/10 mg Filmtabletten (PZN 4978429)
+ 1 more products
Nustendi 180 mg/10 mg Filmtabletten (PZN 4978435)
2026-09-242027-01-25Verzögerung bei der Herstellungregister ↗

Full report history (2 register entries)

Every individual register entry for Bempedosäure, ezetimib in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇦🇹 ATNustendi 180 mg/10 mg Filmtabletten (PZN 4978429)Shortage2026-09-242027-01-25Verzögerung bei der Herstellung
🇦🇹 ATNustendi 180 mg/10 mg Filmtabletten (PZN 4978435)Resolved2026-09-242026-11-05Verzögerung bei der Herstellung

Frequently asked

Is Bempedosäure, ezetimib currently in shortage in Europe?

Yes. As of 28 October 2026, availability issues are reported in: Austria. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Bempedosäure, ezetimib shortage expected to end?

Agency prognoses on file range from 2027-01-25 to 2027-01-25. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Where does this Bempedosäure, ezetimib availability data come from?

Directly from the official medicines-agency register that lists Bempedosäure, ezetimib: BASG (Austria). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Bempedosäure, ezetimib — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/bempedosaure-ezetimib/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Bempedosäure, ezetimib availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/bempedosaure-ezetimib/">Bempedosäure, ezetimib shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Bempedosäure, ezetimib: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 28 October 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.